JOSÉ ÁNGEL
GARCÍA SÁENZ

Profesor asociado de Ciencias de la Salud

Foto de JOSÉ ÁNGEL

Foto de Hospital Universitario Arnau de Vilanova

Hospital Universitario Arnau de Vilanova

Lleida, España

Publicaciones en colaboración con investigadores/as de Hospital Universitario Arnau de Vilanova (3)

2021

Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL
Annals of Oncology, Vol. 32, Núm. 4, pp. 488-499

2012

Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial
Cancer, Vol. 118, Núm. 1, pp. 241-247

2007

Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial
Lancet Oncology, Vol. 8, Núm. 3, pp. 219-225